» Articles » PMID: 38337105

Monte Carlo Optimization Method Based QSAR Modeling of Placental Barrier Permeability

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2024 Feb 10
PMID 38337105
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: In order to ensure that drug administration is safe during pregnancy, it is crucial to have the possibility to predict the placental permeability of drugs in humans. The experimental method which is most widely used for the said purpose is in vitro human placental perfusion, though the approach is highly expensive and time consuming. Quantitative structure-activity relationship (QSAR) modeling represents a powerful tool for the assessment of the drug placental transfer, and can be successfully employed to be an alternative in in vitro experiments.

Methods: The conformation-independent QSAR models covered in the present study were developed through the use of the SMILES notation descriptors and local molecular graph invariants. What is more, the Monte Carlo optimization method, was used in the test sets and the training sets as the model developer with three independent molecular splits.

Results: A range of different statistical parameters was used to validate the developed QSAR model, including the standard error of estimation, mean absolute error, root-mean-square error (RMSE), correlation coefficient, cross-validated correlation coefficient, Fisher ratio, MAE-based metrics and the correlation ideality index. Once the mentioned statistical methods were employed, an excellent predictive potential and robustness of the developed QSAR model was demonstrated. In addition, the molecular fragments, which are derived from the SMILES notation descriptors accounting for the decrease or increase in the investigated activity, were revealed.

Conclusion: The presented QSAR modeling can be an invaluable tool for the high-throughput screening of the placental permeability of drugs.

Citing Articles

The Role of Metal Nanoparticles in the Pathogenesis of Stone Formation.

Labis V, Gaiduk I, Bazikyan E, Khmelenin D, Zhigalina O, Dyachkova I Int J Mol Sci. 2024; 25(17).

PMID: 39273555 PMC: 11394863. DOI: 10.3390/ijms25179609.


Fetus Exposure to Drugs and Chemicals: A Holistic Overview on the Assessment of Their Transport and Metabolism across the Human Placental Barrier.

Kotta-Loizou I, Pritsa A, Antasouras G, Vasilopoulos S, Voulgaridou G, Papadopoulou S Diseases. 2024; 12(6).

PMID: 38920546 PMC: 11202568. DOI: 10.3390/diseases12060114.

References
1.
Pemathilaka R, Reynolds D, Hashemi N . Drug transport across the human placenta: review of placenta-on-a-chip and previous approaches. Interface Focus. 2019; 9(5):20190031. PMC: 6710654. DOI: 10.1098/rsfs.2019.0031. View

2.
Evseenko D, Paxton J, Keelan J . Active transport across the human placenta: impact on drug efficacy and toxicity. Expert Opin Drug Metab Toxicol. 2006; 2(1):51-69. DOI: 10.1517/17425255.2.1.51. View

3.
Collins T . History and evolution of reproductive and developmental toxicology guidelines. Curr Pharm Des. 2006; 12(12):1449-65. DOI: 10.2174/138161206776389813. View

4.
Younglai E, Wu Y, Foster W . Reproductive toxicology of environmental toxicants: emerging issues and concerns. Curr Pharm Des. 2007; 13(29):3005-19. DOI: 10.2174/138161207782110499. View

5.
Yamashita M, Markert U . Overview of Drug Transporters in Human Placenta. Int J Mol Sci. 2021; 22(23). PMC: 8658420. DOI: 10.3390/ijms222313149. View